Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Prostate Cancer and Prostatic Diseases|October 8, 2022
Urinary microbiota and prostatic diseases: the key for the lock? A systematic reviewGeorges Mjaess, Aya Karam, Thierry Roumeguère, et al.
BJUI Compass|January 2, 2025
Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trialNicolas Barry Delongchamps, Alexandre Peltier, Eric Potiron, et al.
Prostate Cancer and Prostatic Diseases|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional samplingJean-Paul Noujeim, Yassir Belahsen, Yolene Lefebvre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway InhibitorsQaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, et al.
Minerva Urology and Nephrology|October 29, 2021
Anterior vs. Retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference?Simone Albisinni, Cyrielle Dasnoy, Romain Diamand, et al.
World Journal of Urology|January 23, 2019
Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomesBrecht Devos, Walid Al Hajj Obeid, Colin Andrianne, et al.
Cancers|June 10, 2023
Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical ProstatectomyCharles Leplat, Teddy Jabbour, Romain Diamand, et al.
Minerva Urology and Nephrology|March 30, 2021
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new eraSimone Albisinni, Nieves Martinez Chanza, Fouad Aoun, et al.
World Journal of Urology|April 3, 2023
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and locationRobin Martin, Yassir Belahsen, Jean-Paul Noujeim, et al.
Urologic Oncology|March 3, 2022
The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric studyRomain Diamand, Marie Hollans, Yoléne Lefebvre, et al.
Pageof 8